تاریخچه درآمد، سود و جریان نقد از صورتهای مالی رسمی.
CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services.
نمودارهای تعاملی و صورتهای مالی کامل ← مدل ارزشگذاری (DCF) ←
| صورت سود و زیان | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| مجموع درآمد | $415.1B | $402.1B | $372.8B | $357.8B | $322.5B | $292.1B | $268.7B | $256.8B | $194.6B | $184.8B | $177.5B | $153.3B | $139.4B | $126.8B | $123.1B | $107.1B | $95.8B | $98.2B | $87.5B | $76.3B | $43.8B |
| سود ناخالص | $58.7B | $55.4B | $51.4B | $54.4B | $54.5B | $52.1B | $49.0B | $45.5B | $31.5B | $28.5B | $28.8B | $26.5B | $25.4B | $23.8B | $22.5B | $20.6B | $20.2B | $20.4B | $18.3B | $16.1B | $11.7B |
| حاشیه سود ناخالص % | 14.1% | 13.8% | 13.8% | 15.2% | 16.9% | 17.8% | 18.2% | 17.7% | 16.2% | 15.4% | 16.2% | 17.3% | 18.2% | 18.8% | 18.3% | 19.2% | 21.1% | 20.7% | 20.9% | 21.1% | 26.8% |
| سود عملیاتی (EBIT) | $8.3B | $10.4B | $8.5B | $13.7B | $8.0B | $13.3B | $13.9B | $12.0B | $4.0B | $9.5B | $10.4B | $9.5B | $8.8B | $8.0B | $7.2B | $6.3B | $6.1B | $6.4B | $6.0B | $4.8B | $2.4B |
| حاشیه سود عملیاتی % | 2.0% | 2.6% | 2.3% | 3.8% | 2.5% | 4.6% | 5.2% | 4.7% | 2.1% | 5.2% | 5.9% | 6.2% | 6.3% | 6.3% | 5.9% | 5.9% | 6.4% | 6.5% | 6.9% | 6.3% | 5.6% |
| سود خالص | $4.9B | $1.8B | $4.6B | $8.3B | $4.3B | $8.0B | $7.2B | $6.6B | ($594M) | $6.6B | $5.3B | $5.2B | $4.6B | $4.6B | $3.9B | $3.5B | $3.4B | $3.7B | $3.2B | $2.6B | $1.4B |
| حاشیه سود خالص % | 1.2% | 0.4% | 1.2% | 2.3% | 1.3% | 2.7% | 2.7% | 2.6% | -0.3% | 3.6% | 3.0% | 3.4% | 3.3% | 3.6% | 3.1% | 3.2% | 3.6% | 3.8% | 3.7% | 3.5% | 3.1% |
| EBITDA | $13.4B | $9.9B | $13.7B | $13.7B | $12.3B | $17.5B | $17.1B | $16.4B | $6.7B | $11.8B | $12.2B | $11.6B | $10.2B | $9.9B | $8.6B | $7.9B | $7.6B | $7.8B | $7.3B | $5.9B | $3.2B |
| سود هر سهم (EPS) | $3.81 | $1.39 | $3.66 | $6.47 | $3.26 | $6.02 | $5.46 | $5.08 | $-0.57 | $6.47 | $4.93 | $4.65 | $3.97 | $3.75 | $3.02 | $2.57 | $2.49 | $2.55 | $2.19 | $1.92 | $1.60 |
| سهام منتشرشده (میلیون) | 1,283M | 1,271M | 1,262M | 1,290M | 1,323M | 1,329M | 1,314M | 1,305M | 1,044M | 1,024M | 1,079M | 1,126M | 1,169M | 1,226M | 1,280M | 1,347M | 1,377M | 1,450M | 1,469M | 1,372M | 853M |
منبع: گزارشهای عمومی شرکت (SEC). پیش از اتکا به هر رقم، آن را در SEC EDGAR بررسی کنید.
ترازنامهها، جریانهای نقدی، دادههای فصلی و نسبتهای مالی کامل در نمایشگر تعاملی CVS در دسترس است. /companies/us/CVS
اطلاعات این وبسایت صرفاً برای اهداف آموزشی و اطلاعرسانی است و توصیه سرمایهگذاری نیست. هیچ هدف قیمتی یا توصیهای منتشر نمیشود.
About TickerBase · Data methodology & sources · Privacy · Terms